Last news
Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting

Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting

...

Yodaplus: Empowering Businesses through Strong Technology Partnerships and Digital Transformation Solutions

Yodaplus: Empowering Businesses through Strong Technology Partnerships and Digital Transformation Solutions

...

Enterprises All over the World Actively Registering for the First CISCE

Enterprises All over the World Actively Registering for the First CISCE

...

Kaiyi Auto new energy strategy anniversary results release

Kaiyi Auto new energy strategy anniversary results release

...

CGTN: Why China is committed to green development

CGTN: Why China is committed to green development

...

True stories of Overseas Filipinos shine in global spotlight, in time for PH Independence Day

True stories of Overseas Filipinos shine in global spotlight, in time for PH Independence Day

...

NaaS Technology Inc. Announces Director Change

NaaS Technology Inc. Announces Director Change

...

OMD Ranked #1 for Competitiveness and Consistency

OMD Ranked #1 for Competitiveness and Consistency

...

menu
menu